14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $9.75 $19.04 Friday, 3rd May 2024 CABA stock ended at $12.39. This is 1.67% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.39% from a day low at $12.20 to a day high of $12.98.
90 days $9.75 $26.35
52 weeks $9.02 $26.35

Historical Cabaletta Bio, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $12.82 $12.98 $12.20 $12.39 810 992
May 02, 2024 $12.51 $13.10 $12.19 $12.60 1 772 688
May 01, 2024 $10.60 $12.69 $10.56 $12.41 2 807 007
Apr 30, 2024 $10.46 $10.79 $10.16 $10.65 1 915 946
Apr 29, 2024 $11.24 $11.39 $9.75 $10.48 5 063 878
Apr 26, 2024 $12.30 $12.30 $10.99 $11.01 2 907 886
Apr 25, 2024 $12.47 $12.68 $11.70 $12.18 1 925 391
Apr 24, 2024 $13.46 $13.67 $12.90 $12.96 738 298
Apr 23, 2024 $13.47 $14.02 $13.30 $13.32 744 958
Apr 22, 2024 $13.43 $13.59 $12.88 $13.32 856 340
Apr 19, 2024 $13.90 $14.28 $13.08 $13.34 1 177 432
Apr 18, 2024 $15.00 $15.00 $13.79 $13.97 1 145 240
Apr 17, 2024 $16.36 $16.36 $15.11 $15.15 1 110 500
Apr 16, 2024 $15.91 $16.42 $15.85 $16.29 641 238
Apr 15, 2024 $17.10 $17.56 $16.00 $16.18 884 812
Apr 12, 2024 $17.74 $18.44 $16.83 $17.03 991 785
Apr 11, 2024 $18.03 $18.03 $17.45 $17.91 754 704
Apr 10, 2024 $18.20 $18.53 $17.60 $17.86 1 040 692
Apr 09, 2024 $17.99 $19.04 $17.69 $18.82 1 107 054
Apr 08, 2024 $17.00 $18.33 $16.85 $18.04 1 039 167
Apr 05, 2024 $15.95 $17.10 $15.82 $16.98 976 008
Apr 04, 2024 $16.79 $17.37 $16.00 $16.11 1 302 863
Apr 03, 2024 $16.34 $16.74 $16.21 $16.44 460 912
Apr 02, 2024 $16.34 $16.77 $16.34 $16.49 482 804
Apr 01, 2024 $16.93 $16.96 $16.24 $16.82 838 426
Click to get the best stock tips daily for free!

About Cabaletta Bio, Inc.

Cabaletta Bio. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART,... CABA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT